A Role for Both Ets and C/EBP Transcription Factors and mRNA Stabilization in the MAPK-dependent Increase in p21Cip-1/WAF1/mda6Protein Levels in Primary Hepatocytes
- 1 September 2000
- journal article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 11 (9) , 2915-2932
- https://doi.org/10.1091/mbc.11.9.2915
Abstract
In primary hepatocytes and HepG2 hepatoma cells, prolonged activation of the p42/44 mitogen-activated protein kinase (MAPK) pathway is associated with a reduction in DNA synthesis, mediated by increased expression of the cyclin-dependent kinase inhibitor protein p21 Cip-1/WAF1/mda6 (p21). This study was performed to evaluate the contribution of transcriptional and post-transcriptional regulation in this response. Prolonged activation of the MAPK pathway in wild-type or p21 null hepatocytes caused a large decrease and increase, respectively, in DNA synthesis. Prolonged activation of the MAPK pathway in either wild-type or p21 antisense HepG2 cells also caused large decreases and increases, respectively, in DNA synthesis. MAPK signaling increased the phosphorylation of the transcription factors Ets2, C/EBPα, and C/EBPβ, and rapidly increased transcription from the p21 promoter via multiple Ets- and C/EBP-elements within the enhancer region. Eight hours after MAPK activation, loss of C/EBPβ or Ets2 function significantly reduced MAPK-stimulated transcription from the p21 promoter and abolished increased p21 protein expression. At this time, MAPK signaling increased both p21 mRNA and p21 protein stabilities that were also demonstrated to be essential for a profound increase in p21 protein levels. Thirty-six hours after MAPK activation, transcription from the p21 promoter was still significantly reduced in cells without either C/EBPβ or Ets2 function; however, these cells were now capable of exhibiting a partial increase in p21 protein expression. In contrast, loss of C/EBPα function modestly reduced MAPK-stimulated transcription from the p21 promoter but strongly inhibited the ability of prolonged MAPK activation to increase protein levels of p21. This data suggested that prolonged enhancement of p21 protein levels may be under posttranscriptional control. In agreement with this hypothesis, prolonged MAPK signaling further increased p21 mRNA stability at 36 h, compared with the 8-h time point. Our data argue that MAPK signaling increased p21 promoter activity via multiple transcription factors, which alone were insufficient for a robust prolonged increase in p21 protein levels in primary hepatocytes, and that to increase p21 protein levels also required enhanced stabilization of p21 mRNA and p21 protein. Collectively, these data suggest that loss of transcription factor and mRNA/protein stabilization functions correlates with an inability of MAPK signaling to cause growth arrest versus proliferation in primary hepatocytes.Keywords
This publication has 61 references indexed in Scilit:
- Inhibition of Mutant p53 Phosphorylation at Serine 15 or Serine 315 Partially Restores the Function of Wild-Type p53Biochemical and Biophysical Research Communications, 1999
- Ras Regulates the Association of Serum Response Factor and CCAAT/Enhancer-binding Protein βPublished by Elsevier ,1999
- Transcriptional Regulatory Signals Define Cytokine-Dependent and -Independent Pathways in Liver RegenerationSeminars in Liver Disease, 1999
- Cell type-specific Transcriptional Activation and Suppression of the α1B Adrenergic Receptor Gene Middle Promoter by Nuclear Factor 1Published by Elsevier ,1998
- α‐Adrenergic inhibition of proliferation in HepG2 cells stably transfected with the α1B‐adrenergic receptor through a p42MAP kinase/p21Cip1/WAF1‐dependent pathwayFEBS Letters, 1998
- Role of the CCAAT/Enhancer Binding Protein-α Transcription Factor in the Glucocorticoid Stimulation of p21 Gene Promoter Activity in Growth-arrested Rat Hepatoma CellsPublished by Elsevier ,1998
- Antioxidant-induced Nuclear Translocation of CCAAT/Enhancer-binding Protein βJournal of Biological Chemistry, 1997
- Mutational Analysis of the p53 and K‐ras Genes and Allelotype Study of the Rb‐1 Gene for Investigating the Pathogenesis of Combined Hepatocellular‐Cholangiocellular CarcinomasJapanese Journal of Cancer Research, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastomaThe Journal of Pathology, 1995